Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning

Sponsor
Sherief Abd-Elsalam (Other)
Overall Status
Recruiting
CT.gov ID
NCT04499885
Collaborator
(none)
62
1
2
126.3
0.5

Study Details

Study Description

Brief Summary

Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning.

Condition or Disease Intervention/Treatment Phase
  • Device: Paraffin oil gastric lavage
  • Device: Gastric lavage with saline and sodium bicarbonate 8.4%
N/A

Detailed Description

The study aims to investigate the Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial
Actual Study Start Date :
Jun 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2030
Anticipated Study Completion Date :
Dec 10, 2030

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Paraffin oil gastric lavafe

Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL of sodium bicarbonate solution

Device: Paraffin oil gastric lavage
Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL of sodium bicarbonate solution
Other Names:
  • Paraffin oil
  • Active Comparator: Saline gastric lavage

    Gastric lavage with saline and sodium bicarbonate

    Device: Gastric lavage with saline and sodium bicarbonate 8.4%
    Gastric lavage with saline and sodium bicarbonate 8.4%
    Other Names:
  • Saline gastric lavage
  • Outcome Measures

    Primary Outcome Measures

    1. Number of deaths [6 months]

      The number of deaths

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • • Patients with symptomatic acute aluminum phosphide poisoning
    Exclusion Criteria:
    • • Pregnant and lactating women

    • Asymptomatic patients with history of acute aluminum phosphide exposure.

    • Patients with ingestion or exposure to other substances in addition to aluminum phosphide.

    • Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).

    • Patients with previous medical intervention (had gastric lavage in any medical center before admission).

    • Patients with disturbed consciousness level

    • Patients with post cardiac arrest cases

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sherief Abd-Elsalam Tanta Egypt

    Sponsors and Collaborators

    • Sherief Abd-Elsalam

    Investigators

    • Principal Investigator: Nadia Ezzat Helal, Ass. Prof., Forensic medicine Department- Tanta University
    • Principal Investigator: Ayman Nagy, ass. Prof., Forensic medicine Department- Tanta University
    • Principal Investigator: Ghada N. El-Sarnagawy, ass. Prof., Forensic medicine Department- Tanta University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sherief Abd-Elsalam, Ass. Prof. Tropical Medicine, Tanta University
    ClinicalTrials.gov Identifier:
    NCT04499885
    Other Study ID Numbers:
    • ghada protocol
    First Posted:
    Aug 5, 2020
    Last Update Posted:
    Aug 5, 2020
    Last Verified:
    Aug 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 5, 2020